Integer Holdings Corporation is one of the world's largest contract development and manufacturing organisations for medical devices, with over 10,000 employees and more than 80 years of industry experience. The company operates a global manufacturing network and provides comprehensive services spanning rapid prototyping, research and development, and scalable production to device manufacturers across cardiac rhythm management, neuromodulation, and cardio-vascular markets.
Integer's service offering ranges from early-stage R&D through full-scale manufacturing. The company's R&D Velocity programme combines advanced laboratory capabilities with manufacturing expertise to help clients accelerate product development and market entry. Its established brands - including Greatbatch Medical, Lake Region Medical, and Electrochem - serve established and emerging medical device companies, with Integer's technology found in most major medical device brands globally.
The company is publicly listed on the New York Stock Exchange under the ticker ITGR. Integer positions itself as a partner for innovation in medical devices, emphasising both manufacturing excellence and technological capability to support the development of breakthrough treatments.
